DealAbcuro, a Newton, MA-based rare disease immunology biotech, raised $66 million in a Series D fundraising round led by New Leaf Venture Partners with participation from Rock Springs Capital and RA Capital Management.
More on MedCity News →
OTHER
08/29/2026
Sonera, Inc., a Berkeley, CA-based neural signal sensor company, was...
Medulance, a New Delhi-based tech-enabled ambulance network, raised ₹24...
Moonwalk Biosciences, a South San Francisco, CA-based RNAi therapies for...
Norbert Health, a Brooklyn, NY-based autonomous robotic nursing platform,...
Thyme Care, a Nashville-based oncology care navigation platform, raised...
Scan.com, an Atlanta-based diagnostic imaging booking platform, raised $90...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
